(Q37789954)

23 August 2017

title

Overview of expression of hepatitis B surface antigen in transgenic plants (English)

1 reference

23 August 2017

1 reference

1 reference

Zheng-jun Guan

1

1 reference

23 August 2017

Bin Guo

2

1 reference

23 August 2017

Yan-lin Huo

3

1 reference

23 August 2017

Zheng-ping Guan

4

1 reference

23 August 2017

Ya-hui Wei

5

1 reference

23 August 2017

language of work or name

English

0 references

publication date

16 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

28

1 reference

23 August 2017

issue

46

1 reference

23 August 2017

page(s)

7351-7362

1 reference

Towards immunotherapy for chronic hepatitis B virus infections

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Molecular virology and pathogenesis of hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

7 January 2021

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Viral vectors for the expression of proteins in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Breakthrough in chloroplast genetic engineering of agronomically important crops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Plant-based production of biopharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Expression of hepatitis B surface antigen in transgenic plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Immunogenicity of transgenic plant-derived hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Plant-based immunocontraceptive control of wildlife--"potentials, limitations, and possums".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Polypeptides of hepatitis B surface antigen produced in transgenic potato

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Production of hepatitis B surface antigen in transgenic plants for oral immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Oral immunization with hepatitis B surface antigen expressed in transgenic plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Expression and characterization of hepatitis B surface antigen in transgenic potato plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Synthesis of hepatitis B virus surface antigen in tomato plants transgenic for the preS2-S gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Plant-based production of xenogenic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Expression of hepatitis B surface antigen in transgenic banana plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Immunogenic measles antigens expressed in plants: role as an edible vaccine for adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Agrobacterium-mediated transformation of yellow lupin to generate callus tissue producing HBV surface antigen in a long-term culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Transgenic lettuce seedlings carrying hepatitis B virus antigen HBsAg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

A plant-derived edible vaccine against hepatitis B virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Expression of hepatitis B surface antigen in tobacco cell suspension cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

The green revolution: plants as heterologous expression vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

High-level expression of the neutralizing epitope of porcine epidemic diarrhea virus by a tobacco mosaic virus-based vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

The full-length clone of cucumber green mottle mosaic virus and its application as an expression system for Hepatitis B surface antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Identification of methyl jasmonate and salicylic acid response elements from the nopaline synthase (nos) promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Immediate early transcription activation by salicylic acid via the cauliflower mosaic virus as-1 element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Production of recombinant proteins in plant root exudates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Production of recombinant proteins in tobacco guttation fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Role of B cells in antigen presentation of the hepatitis B core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Immunological properties of hepatitis B core antigen fusion proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

The use of viral vectors to produce hepatitis B virus core particles in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Activation of fibronectin gene expression by hepatitis B virus x antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Molecular biology of hepatitis B virus e antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

The molecular basis of hepatitis B e antigen (HBeAg)-negative infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Screening of 25 compounds isolated from Phyllanthus species for anti‐human hepatitis B virus in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Immunogenicity in humans of an edible vaccine for hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Expression of the hepatitis B surface S and preS2 antigens in tubers of Solanum tuberosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Comparative analysis of HBV M-antigen production in leaves of individual transgenic carrot plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Assessment of the utility of the tomato fruit-specific E8 promoter for driving vaccine antigen expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

The abundant 31-kilodalton banana pulp protein is homologous to class-III acidic chitinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

Transgenic plants for vaccine production: expectations and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.100

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.08.100

1 reference

23 August 2017

1 reference